ZYNGENIA INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are ABEXXA BIOLOGICS INC, NANJING LEADS BIOLABS CO LTD and ANWITA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | New Zealand | 2 | |
#8 | Brazil | 1 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hilbert David M | 25 |
#2 | Lafleur David | 21 |
#3 | Roschke Viktor | 21 |
#4 | Kiener Peter | 21 |
#5 | David M Hilbert | 2 |
#6 | Viktor Roschke | 2 |
#7 | Peter Kiener | 2 |
#8 | David Lafleur | 2 |
#9 | Lafleur David D | 1 |
#10 | Hilbert David M Dm | 1 |
Publication | Filing date | Title |
---|---|---|
EP2968541A2 | Multivalent and monovalent multispecific complexes and their uses | |
WO2014028776A1 | Monovalent and multivalent multispecific complexes and uses thereof | |
NZ618334A | Multivalent and monovalent multispecific complexes and their uses | |
EP2673297A2 | Monovalent and multivalent multispecific complexes and uses thereof | |
WO2012009705A1 | Ang-2 binding complexes and uses thereof |